Tuesday, July 30, 2024 9:02:06 PM
Meirluc,
I believe that much depends on how the news is handled. If these events occur and no one in the investment public knows about it, you could be right. I don't believe that will happen, but anything is possible. I believe the news of approval will get substantial notice and once the price takes off, the MM's won't be able to hold it down. I do also believe the company has other news to release once we have an approval and that will keep the share price moving up.
Companies with approved potentially blockbuster drugs don't have market caps below a billion, not when at least a few billion are justified. I just don't believe the MM's, bashers, AdamF, etc. can keep this down once an approval is out. As for the court case, it's the frosting on the cake, but approval is the key to success and it will get us there. If there is any equity partnership, it will be under terms the LP agrees with, and I don't see that happening at below double digit share prices, but of course I could be wrong about that.
Gary
I believe that much depends on how the news is handled. If these events occur and no one in the investment public knows about it, you could be right. I don't believe that will happen, but anything is possible. I believe the news of approval will get substantial notice and once the price takes off, the MM's won't be able to hold it down. I do also believe the company has other news to release once we have an approval and that will keep the share price moving up.
Companies with approved potentially blockbuster drugs don't have market caps below a billion, not when at least a few billion are justified. I just don't believe the MM's, bashers, AdamF, etc. can keep this down once an approval is out. As for the court case, it's the frosting on the cake, but approval is the key to success and it will get us there. If there is any equity partnership, it will be under terms the LP agrees with, and I don't see that happening at below double digit share prices, but of course I could be wrong about that.
Gary
Bullish
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
